Intermediate-Size Population Expanded Access Program (EAP) for cilta-cel Out-of-Specification (OOS) in Patients with Multiple Myeloma
Categories (click each to see list of all clinical trials associated with that category): Cellular Therapy Support Service - CAR-T (ONC), Myeloma/Plasma Cell Dyscrasia (ONC)
Current Status: Open
Phase: N/A (Cancer Control)
Principal Investigator: D'Angelo, Christopher
Eligibility: https://clinicaltrials.gov/study/NCT05346835?term=NCT05346835&rank=1
Summary
Consideration of use of out of specification CAR-T product.